GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Alfresa Holdings Corp (OTCPK:ARHCF) » Definitions » Change In Receivables

Alfresa Holdings (Alfresa Holdings) Change In Receivables : $0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Alfresa Holdings Change In Receivables?

Alfresa Holdings's change in receivables for the quarter that ended in Dec. 2023 was $0 Mil. It means Alfresa Holdings's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

Alfresa Holdings's change in receivables for the fiscal year that ended in Mar. 2024 was $-168 Mil. It means Alfresa Holdings's Accounts Receivable increased by $168 Mil from Mar. 2023 to Mar. 2024 .

Alfresa Holdings's Accounts Receivable for the quarter that ended in Dec. 2023 was $4,868 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Alfresa Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 85.05.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Alfresa Holdings's liquidation value for the three months ended in Dec. 2023 was $-1,539 Mil.


Alfresa Holdings Change In Receivables Historical Data

The historical data trend for Alfresa Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alfresa Holdings Change In Receivables Chart

Alfresa Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 185.19 38.52 -62.98 -197.50 -168.16

Alfresa Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alfresa Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alfresa Holdings  (OTCPK:ARHCF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Alfresa Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=4867.931/5222.525*91
=85.05

2. In Ben Graham's calculation of liquidation value, Alfresa Holdings's accounts receivable are only considered to be worth 75% of book value:

Alfresa Holdings's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1394.735-7193.785+0.75 * 4867.931+0.5 * 1218.907
=-1,539

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alfresa Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Alfresa Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Alfresa Holdings (Alfresa Holdings) Business Description

Traded in Other Exchanges
Address
1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004
Alfresa Holdings Corp is a holding company engaged in the distribution of drugs. The company is in the Ethical Pharmaceuticals Wholesaling Business, the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the Medical-Related Business. It mainly provides distributes diagnostic reagents and medical devices/equipment, health foods, supplements and other products to drug stores and pharmacies. The firm manufactures and markets high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices.

Alfresa Holdings (Alfresa Holdings) Headlines

No Headlines